Kamal Kumar Sethi
About
In The Last Decade
Kamal Kumar Sethi
44 papers receiving 576 citations
Peers
Comparison fields: 5 of 75
- Cardiology and Cardiovascular Medicine 325
- Surgery 206
- Pulmonary and Respiratory Medicine 181
- Epidemiology 175
- Hepatology 75
Countries citing papers authored by Kamal Kumar Sethi
This map shows the geographic impact of Kamal Kumar Sethi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kamal Kumar Sethi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kamal Kumar Sethi more than expected).
Fields of papers citing papers by Kamal Kumar Sethi
This network shows the impact of papers produced by Kamal Kumar Sethi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kamal Kumar Sethi. The network helps show where Kamal Kumar Sethi may publish in the future.
Co-authorship network of co-authors of Kamal Kumar Sethi
This figure shows the co-authorship network connecting the top 25 collaborators of Kamal Kumar Sethi. A scholar is included among the top collaborators of Kamal Kumar Sethi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kamal Kumar Sethi. Kamal Kumar Sethi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 1 | |
| 5 | 8 | |
| 6 | 4 | |
| 7 | 9 | |
| 8 | 5 | |
| 9 | Safety and efficacy of indigenously developed and manufactured bivalirudin in moderate/high-risk Indian patients undergoing percutaneous coronary intervention: the Bivaflo Registry. | 0 |
| 10 | 10 | |
| 11 | 86 | |
| 12 | 67 | |
| 13 | 56 | |
| 14 | 41 | |
| 15 | 6 | |
| 16 | 3 | |
| 17 | 24 | |
| 18 | 2 | |
| 19 | 9 | |
| 20 | 72 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.